Norio Kohno

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 854 citations

End-of-study Results, Breast Oncology, Medicine +8

Zoledronic Acid Significantly Reduces Skeletal Complications Compared With Placebo in Japanese Women With Bone Metastases From Breast Cancer: A Randomized, Placebo-Controlled Trial

Norio Kohno, Kenjiro Aogi, Hironobu Minami et al. · Journal of Clinical Oncology · 2005 · 545 citations

Oral Uracil and Tegafur Compared With Classic Cyclophosphamide, Methotrexate, Fluorouracil As Postoperative Chemotherapy in Patients With Node-Negative, High-Risk Breast Cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial

Toru Watanabe, Muneaki Sano, Shigemitsu Takashima et al. · Journal of Clinical Oncology · 2009 · 93 citations

Coexpression of Arp2 and WAVE2 predicts poor outcome in invasive breast carcinoma

Keiichi Iwaya, Norio Kohno, Kiyoshi Mukai · Modern Pathology · 2007 · 87 citations · Full text

Breast Oncology, Poor Outcome, Medicine +9

Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance

Hitomi Imachi, Koji Murao, Hiroaki Dobashi et al. · Breast Cancer Research and Treatment · 2009 · 63 citations

Systems Biology, Breast Oncology, Tamoxifen Resistance +11